Dual diagnosis psychosis and substance use disorders - Theoretical foundations and treatment;Doppeldiagnose psychose und sucht - Grundlagen und therapie

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 36, Issue 4, 2008, Pages 245-253

  Gouzoulis Mayfrank, Euphrosyne ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cannabis; Comorbidity; Dual diagnosis; Psychosis; Substance use disorders

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER; NALTREXONE; NEUROLEPTIC AGENT;

CANNABIS ADDICTION; CLINICAL RESEARCH; COGNITIVE THERAPY; COMORBIDITY; DISEASE PREDISPOSITION; FAMILY THERAPY; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; LONG TERM CARE; MOTIVATION; OUTPATIENT CARE; PATIENT COMPLIANCE; PREVALENCE; PSYCHIATRIC TREATMENT; PSYCHOEDUCATION; PSYCHOSIS; RELAPSE; REVIEW; SCHIZOPHRENIA; SOCIAL ADAPTATION; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 49249117361     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: 10.1024/1422-4917.36.4.245     Document Type: Review

References (44)

1. Ajdacic-Gross, V., Lauber, C., Warnke, I., Haker, H., Murray, R. M. & Rossler, W. (2007). Changing incidence of psychotic disorders among the young in Zurich. Schizophrenia Research, 95, 9-18.
2. Andreasson, S., Allebeck, P., Engstrom, A. & Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, 2, 1483-1486.
3. Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A. & Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325, 1212-1213.
4. Baker, A., Bucci, S., Lewin, T. J., Kay-Lambkin, F., Constable, P. M. & Carr, V. J. (2006). Cognitivebehavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. British Journal of Psychiatry, 188, 439-448.
5. Bennett, M. E., Bellack, A. S. & Gearon, J. S. (2001). Treating substance abuse in schizophrenia. An initial report. Journal of Substance Abuse Treatment, 20, 163-175.
6. Boydell, J., van, O. J., Caspi, A., Kennedy, N., Giouroukou, E., Fearon, P., Farrell, M., & Murray, R. M. (2006). Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychological Medicine, 36, 1441-1446.
7. BZgA (2007). Cannabiskonsum der Jugendlichen und jungen Erwachsenen in Deutschland.
8. Cantwell, R., Brewin, J., Glazebrook, C., Dalkin, T., Fox, R., Medley, I. & Harrison, G. (1999). Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry, 174, 150-153.
9. Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braith-waite, A., Poulton, R. & Craig, I. W. (2005). Moderation of the effect of adolescentonset cannabis use on adult psychosis by a functional polymorphism in the catechol-Omethyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57, 1117-1127.
10. Chambers, R. A., Krystal, J. H. & Self, D. W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50, 71-83.
11. Coulston, C. M., Perdices, M. & Tennant, C. C. (2007). The neuropsychological correlates of cannabis use in schizophrenia: Lifetime abuse/dependence, frequency of use, and recency of use. Schizophrenia Research, 96, 169-184.
12. D'Amelio, R. & Behrendt, B. W. T. (2007). Psychoedukation Schizophrenie und Sucht. Manual zur Leitung von Patienten-und Angehörigengruppen. München: Elsevier/Urban & Fischer.
13. Dixon, L., Haas, G., Weiden, P. J., Sweeney, J. & Frances, A. J. (1991). Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry, 148, 224-230.
14. Dixon, L., Adams, C. & Lucksted, A. (2000). Update on family psychoeducation for schizophrenia. Schizophrenia Bulletin, 26, 5-20.
15. Drake, R. E., Mercer-McFadden, C., Mueser, K. T., McHugo, G. J. & Bond, G. R. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589-608.
16. Drake, R. E. & Mueser, K. T. (2000). Psychosocial approaches to dual diagnosis. Schizophrenia Bulletin, 26, 105-118.
17. Drake, R. E., Mueser, K. T., Brunette, M. F. & McHugo, G. J. (2004). A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal, 27, 360-374.
18. Ferdinand, R. F., Sondeijker, F., van der, E. J., Selten, J. P., Huizink, A. & Verhulst, F. C. (2005). Cannabis use predicts future psychotic symptoms, and vice versa. Addiction, 100, 612-618.
19. Pergusson, D. M., Horwood, L. J. & Ridder, E. M. (2005). Tests of causal linkages between cannabis use and psychotic symptoms. Addiction, 100, 354-366.
20. Gouzoulis-Mayfrank, E. (2007). Komorbidität Psychose und Sucht - Grundlagen und Praxis. (2. Auflage). Darmstadt: Steinkopff.
21. Green, A. I. (2005). Schizophrenia and comorbid substance use disorder: effects of antipsychotics. Journal of Clinical Psychiatry, 66, Suppl 6, 21-26.
22. Haddock, G., Barrowclough, C., Tarrier, N., Moring, J., O'Brien, R., Schofield, N., Quinn, J., Palmer, S., Davies, L., Lowens, I., McGovern, J. & Lewis, S. (2003). Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised con-trolled trial. British Journal of Psychiatry, 183, 418-126.
23. Hall, W. & Degenhardt, L. (2007). Prevalence and correlates of cannabis use in developed and developing countries. Current Opinion in Psychiatry, 20, 393-397.
24. Hambrecht, M. & Hafner, H. (1996). Substance abuse and the onset of schizophrenia. Biological Psychiatry, 40, 1155-1163.
25. Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H. U. & Van Os, J. (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal, 330, 11-14.
26. Hickmann, M., Vickerman, P., Macleod, J., Kirkbride, J. & Jones, P. (2007). Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction, 102, 597-606.
27. Jockers-Scherübl, M., Wolf T., Radzei, N., Schlattmann, P., Rentzsch, J., Gomez-Carrillo de Castro, A. & Kühl, K.-P. (2007). Cannabis induces differential cognitive changes in schizophrenic patients and in healthy controls. Progress in Neuropsychopharmacology & Biological Psychiatry, 31, 1054-1063.
28. Kirkbride, J. B., Fearon, P., Morgan, C., Dazzan, P., Morgan, K., Tarrant, J., Lloyd, T., Holloway, J., Hutchinson, G., Leff, J. P., Mallett, R. M., Harrison, G. L., Murray, R. M. & Jones, P. B. (2006). Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3 center AeSOP study. Archives of General Psychiatry, 63, 250-258.
29. Linszen, D. & van Amelsvoort T. (2007). Cannabis and psychosis: an update on course and biological plausible mechanisms. Current Opinion in Psychiatry, 20, 116-120.
30. Miller, W. R. & Rollnick, S. (1991). Motivational Interviewing. New York: Guilford Press.
31. Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M. & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370, 319-328.
32. Mueser, K. T., Drake, R. E. & Wallach, M. A. (1998). Dual diagnosis: a review of etiological theories. Addictive Behaviors, 23, 717-734.
33. Mueser, K. T. & Pox, L. (2002). A family intervention program for dual disorders. Community Mental Health Journal, 38, 253-270.
34. Penk, W. E., Flannery, R. B., Jr., Irvin, E., Geller, J., Fisher, W. & Hanson, M. A. (2000). Characteristics of substance-abusing persons with schizophrenia: the paradox of the dually diagnosed. Journal of Addictive Disorders, 19, 23-30.
35. Petrakis, I. L., Nich, C. & Ralevski, E. (2006). Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophrenia Bulletin, 32, 644-654.
36. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L. & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264, 2511-2518.
37. Schnell, T. & Gouzoulis-Mayfrank, E. (2007). KomPASs: Komorbidität Psychose und Abhängigkeit: Skills Training. In: E.Gouzoulis-Mayfrank (Ed.), Komorbidität Psychose und Sucht - Grundlagen und Praxis (2. Auflage, pp. 105-172). Darmstadt: Steinkopff.
38. Sevy, S., Robinson, D. G., Holloway, S., Alvir, J. M., Woerner, M. G., Bilder, R., Goldman, R., Lieberman, J. & Kane, J. (2001). Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica, 104, 367-374.
39. Stirling, J., Lewis, S., Hopkins, R. & White, C. (2005). Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophrenia Research, 75, 135-137.
40. Van Mastrigt, S., Addington, J. & Addington, D. (2004). Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology, 39, 69-72.
41. Van Os, J., Bak, M., Hanssen, M., Bijl, R. V., De, G. R. & Verdoux, H. (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology, 156, 319-327.
42. Wittchen, H. U., Fröhlich, C., Behrendt, S., Günther, A., Rehm, J., Zimmermann, P., Lieb, R. & Perkonigg, A. (2007). Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug & Alcohol Dependence, 88, Suppl. 1, S60-S70.
43. Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I. & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal, 325, 1199.
44. Ziedonis, D. M. & D'Avanzo, K. (1998). Schizophrenia and Substance abuse. In: H. R. Kranzler & B. J. Rounsaville (Eds.), Dual diagnosis and treatment (pp. 427-465). New York: Marcel Dekker.